SCHEMBL9048859

SCHEMBL9048859

O=C(O)CC1Cc2cc(O)ccc2C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.58
CYP26A1 O43174 7/20 0.54
MEN1 O00255 2/20 0.50
GLA P06280 2/20 0.50
KMT2A Q03164 2/20 0.50
GAA P10253 1/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
NR1I2 O75469 1/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
HSP90AA1 P07900 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7072860 0.86 METAP1 (0.59) CYP19A1CYP26A1METAP1DGAT1ITGB3
SCHEMBL4622497 0.85 CYP26A1 (0.70) CYP19A1CYP26A1DGAT1ITGB3ITGA2B
SCHEMBL9243642 0.83 METAP1 (0.59) CYP19A1CYP26A1METAP1DGAT1ITGB3
SCHEMBL6268218 0.83 HTR2C (0.51) CYP19A1METAP1DGAT1ITGB3ITGA2B
SCHEMBL10756226 0.83 CYP26A1 (0.45) CYP19A1CYP26A1GAALMNAMAPT
SCHEMBL9854906 0.82 CYP19A1 (0.53) CYP19A1CYP26A1MEN1GLAKMT2A
SCHEMBL6272399 0.80 METAP1 (0.65) CYP19A1CYP26A1METAP1ACHECYP24A1
SCHEMBL27236990 0.79 HTR1A (0.41) CYP19A1MEN1KMT2AGAAKDM4E
SCHEMBL6695612 0.79 METAP1 (0.57) CYP19A1METAP1ACHE
SCHEMBL10750981 0.77 ITGB3 (0.51) MEN1KMT2ANPC1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed